GAP funding

UI spinout company VIDA Diagnostics raises $5.1 million Series B funding

VIDA Diagnostics Inc., a medical software and services company based in the UI BioVentures Center and created through research at the UI College of Engineering, recently announced the company raised $5.1 million in Series B funding.

Read more about UI spinout company VIDA Diagnostics raises $5.1 million Series B funding

Voxello awards mount as company prepares to take noddle to market

With an anticipated launch this summer of its signature invention—a device that allows patients with physical impairments to communicate with hospital staff—University of Iowa spinout company Voxello continues to draw significant investor interest while clinical trials are underway.

Read more about Voxello awards mount as company prepares to take noddle to market

UI gap program seeks pre-proposals for commercialization funding

Sometimes, researchers need a helping hand to close the distance between a brilliant idea and a commercially viable product, service, or business.

That’s where the University of Iowa’s GAP Funding Program comes in.

Read more about UI gap program seeks pre-proposals for commercialization funding

UI professor works toward HIV inactivation

Hillel Haim, University of Iowa assistant professor of microbiology, is working on establishing new approaches to inactivate human immunodeficiency virus type 1 (HIV-1) and to increase its sensitivity to antibodies elicited by vaccines.

Read more about UI professor works toward HIV inactivation

UI professor creates urgent seizure treatment device

Read more about UI professor creates urgent seizure treatment device

UI Professor receives GAP funding for anti-cancer compound

Five-hundred meters underwater in the south Pacific, a marine sponge contains a compound with unique anti-cancer properties. The only problem is supply. The sponge is not quite easily accessible, and when it is found, it typically doesn’t yield enough material to study.

Read more about UI Professor receives GAP funding for anti-cancer compound

UI Professor develops microRNA inhibitors

Brad Amendt, UI professor of anatomy and cell biology, is about to go commercial with his new class of microRNA inhibitors to be used in tissue reprogramming, tissue engineering, and bone formation. His team has developed a new plasmid based series of microRNA reagents.

Read more about UI Professor develops microRNA inhibitors

UI awards gap funding to 11 faculty innovators

The University of Iowa’s UI Ventures program has awarded $750,000 in GAP funding to 11 awardees for FY2015, helping faculty and other researchers bridge the cost of translating their work into commercial products, services, and businesses.

Read more about UI awards gap funding to 11 faculty innovators

Office of the Vice President for Research

GAP funding

UI spinout company VIDA Diagnostics raises $5.1 million Series B funding

Voxello awards mount as company prepares to take noddle to market

UI gap program seeks pre-proposals for commercialization funding

UI professor works toward HIV inactivation

UI professor creates urgent seizure treatment device

UI Professor receives GAP funding for anti-cancer compound

UI Professor develops microRNA inhibitors

UI awards gap funding to 11 faculty innovators

Office of Research units

Research Administration

Core Facilities

Museums & Collections

Centers

You are here

GAP funding